Guide · sources and program records linked below
How to appeal a patient assistance denial
There may be no formal appeal to file with the program. On 10/31/26 we read five drug maker program documents, and none describes a process for appealing the program’s own decision. Ask the program whether it reviews denials. An appeal to your insurer is a separate process with its own rights and deadlines.
What five program documents say about appeals, and how an appeal to your insurer or Medicare Part D plan differs.
The short answer
- None of the five documents describes an appeal to the program.
- Ask the program directly.
- Medicare Part D gives 65 days for the first appeal to the plan.
What the program documents say
This table covers what we read on 10/31/26. It speaks only for these documents. It does not show that these or other programs refuse to review a denial by phone or some other route.
| Program | Appeal to the program | What the document says |
|---|---|---|
| NovoCare | Not described | Asks uninsured applicants for proof of a Medicaid denial, and Medicare insulin patients below 150% of the federal poverty level for proof of an Extra Help denial. |
| Pfizer RxPathways | Not described | May require patients to provide proof of denial prior to being considered for enrollment. |
| AZ&Me | Not described | The FAQ does not cover denials or appeals. |
| Eisai (LENVIMA) | Not described | A patient whose insurance does not cover LENVIMA must show the insurer denied a first-level appeal. Insufficient coverage is a separate route, and the document does not apply that requirement to it. |
| Teva Cares | Not described | Without a required outcome letter, the application is incomplete and is not processed. |
What to ask the program
Ask whether the program reviews denials, what reason it recorded, and what information could change the result.
Appealing to a health plan
An appeal to your insurer challenges the coverage decision, not the program’s decision. HealthCare.gov says that if your insurer refuses to pay a claim or ends your coverage, you have the right to an internal appeal and an independent external review, and that the insurer must speed up an urgent internal appeal. That page does not list which plan types it covers, so check your plan’s notice. This can matter to a program: Eisai requires that the insurer has denied a first-level appeal before it accepts a patient whose insurance does not cover LENVIMA.
Appealing to a Medicare drug plan
In Medicare Part D, you, your representative or your prescriber must ask for the first appeal within 65 days of the date on the plan’s denial notice, according to Medicare.gov. If you miss the deadline, you must give a reason. The plan decides a standard benefits appeal in 7 days, a payment appeal in 14 days and a fast appeal in 72 hours. Medicare.gov lists five appeal levels, and later levels have their own deadlines. To ask for an exception, your prescriber must explain the medical reason.
Sources and next steps
- NovoCare · Read 10/31/26
- Pfizer RxPathways · Read 10/31/26
- AZ&Me FAQ · Read 10/31/26
- Eisai Patient Support (LENVIMA) · Read 10/31/26
- Teva Cares · Read 10/31/26
- Medicare.gov: appeals in a Medicare drug plan · Read 10/31/26
- HealthCare.gov: appealing a health plan decision · Read 10/31/26
- What to do after an application is denied
This is information about program rules. Confirm the current terms with the program or plan. Treatment decisions belong with your prescriber.
Check what you qualify for